Ottawa Health Research Institute
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 10K
- Market Cap
- -
Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform
Not Applicable
Completed
- Conditions
- Mobile AppsImmunizationAdverse Event Following Immunisation
- Interventions
- Device: Mobile app - CanImmunizeDevice: Web based notification
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- The Ottawa Hospital
- Target Recruit Count
- 2408
- Registration Number
- NCT05794113
- Locations
- 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
Standardization of Post-operative Opiate Prescriptions for Same-day Ankle and Wrist Fracture Surgeries
Not Applicable
- Conditions
- Prescription Opioid AbuseSurgeryOpioid UseFracture WristPost-operative PainFracture, Ankle
- Interventions
- Other: Standardized opiate prescription
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- The Ottawa Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05322564
Minimal Invasive Surgical Intracerebral Hemorrhage Removal
Not Applicable
Not yet recruiting
- Conditions
- Intracranial Hemorrhages
- Interventions
- Device: Minimally invasive surgical (MIS) intracranial hemorrhage Evacuation
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- The Ottawa Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT05138341
Evaluation of a Novel Axillary Lymph Node Ink Localization Technique: A Feasibility Study
Not Applicable
Withdrawn
- Conditions
- Breast CancerAxillary Lymphadenitis
- Interventions
- Device: Black-Eye Ink
- First Posted Date
- 2019-10-23
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- The Ottawa Hospital
- Registration Number
- NCT04136496
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
Phase 2
- Conditions
- Ovarian Cancer
- First Posted Date
- 2004-08-30
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Ottawa Regional Cancer Centre
- Registration Number
- NCT00002487
- Locations
- 🇨🇦
Ottawa Regional Cancer Centre - Civic Campus, Ottawa, Ontario, Canada
🇨🇦Ottawa Regional Cancer Center - General Division, Ottawa, Ontario, Canada
Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy
Phase 2
- Conditions
- Lymphoma
- First Posted Date
- 2004-08-30
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Ottawa Regional Cancer Centre
- Registration Number
- NCT00002488
- Locations
- 🇨🇦
Ottawa Regional Cancer Center - General Division, Ottawa, Ontario, Canada
🇨🇦Ottawa Regional Cancer Centre - Civic Campus, Ottawa, Ontario, Canada
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
Phase 1
- Conditions
- Lung Cancer
- First Posted Date
- 2004-03-26
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Ottawa Regional Cancer Centre
- Target Recruit Count
- 30
- Registration Number
- NCT00002887
- Locations
- 🇨🇦
Ottawa Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Phase 2
Completed
- Conditions
- Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck CancerLiver CancerMalignant MesotheliomaPheochromocytomaSarcoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Ottawa Regional Cancer Centre
- Target Recruit Count
- 30
- Registration Number
- NCT00002608
- Locations
- 🇨🇦
Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath